Get started

Sharemarket

Mid-cap Pharma Company might get a booster dose.Mid-cap Pharma Company might get a booster dose? The 31,177.59 Cr. worth mid-cap Pharma company, Laurus Labs Ltd. gave a massive 96% CAGR (3yrs.) in the past. The share price of the company made a high of Rs. 723.55 after which it saw a downturn is now giving signals of its trend reversal to Bullish. The share price of the company made an 'inverted Head and Shoulders' pattern which is a bullish trend reversal pattern. Also, the share price might also see a 50 & 100 EMA crossover in the next 1-3 trading session which again makes it a positive for traders & investors. In clear words, the target for the share is 665 - 685, with a mid-term view of 2- 12 weeks. The stock might retest the level of 550 - 560 (precisely Rs. 555) which would also make it the ultimate support. Also, please consult your financial advisor before entering into any trade. This piece of knowledge is shared only for educational purposes. Thank You & keep learning!
NSE:LAURUSLABSLong
by GautamNegi
Why is Allbirds stock down 70% since its IPO?Allbirds (NASDAQ: BIRD), the New Zealand footwear company, was listed on the Nasdaq in November 2021 at a starting price of US $21.21 and found a range between US $20 and $30 for one month. Its mission to create the world's first carbon-neutral shoe brand appealed to investors, perhaps those of the ESG persuasion, who have pushed a record US $650 billion of funds into ESG project in 2021. As noted by the Financial Post, Allbirds mentioned the word "sustainability" 112 times in its IPO filing. Starting December 2021, up to the time of writing, BIRD stock has plummeted to US $5.99, and its market cap has reduced to US $4 billion from US $900 million. While the company has been performing admirably, as per its quarterly report released on February 23, BIRD's stock price has flown south for the winter, as it's caught up in the same winddown experienced by many other of its growth stock brethren. Over the past few months, investors have generally turned against growth stocks ever since it became apparent that the US Federal Reserve would be hiking interest rates to combat the countries inflation that is famously at a 40-year high. Allbirds is firmly in the category of a growth stock and a unique growth stock at that, as its typically eco-conscious customers return less frequently to the Allbirds checkout aisle. This means its growth strategy and attempt to build brand awareness has to be particularly aggressive. As such, Allbirds is ploughing its cash flow and cash reserves into gaining more customers, opening brick-and-mortar stores, and expanding its apparel range. The company is projecting revenue of US $360 million in the 2022 financial year, a big lift in revenue over 2021, but still expects to make a loss of approximately US $11 million. Interestingly, it should be noted that about US $8 million of this shortfall is attributed to compliance costs associated with becoming a public company. Even though Allbirds may bootstrap its growth expenses with its cash flow and reserves, it does have US $40 million available under a revolving credit agreement. The cost of borrowing capital moving forward, should it need to meet its aggressive growth strategy, may become increasingly costly in line with the US Federal Reserve's interest rate hikes.
NASDAQ:BIRD
by BlackBull_Markets
11
Market Recap and levels to watch for the coming sessionsMorning Jumpstart 25-01-22 US Bounced bark hard from a weak open after trapping and squeezing some sellers. Bargain hunters were out in force expecting that the selloff is over and its time to buy the Dip. I feel that we may have seen the highs put in place and may expect a further unwind of bulls as inflation and interest rate rises kick in. More in the video.... Thanks for watching and please take some time to check out the website.
CBOT:ZT1!
by TradeTheStructure
Could be a slippery slide lower on the ASXThe ASX200 is under pressure as price falls into the weekend on stock market meltdown fears. US rate rises and inflation, along with other concerns, are weighing on bullish sentiment and testing the patients of buyers. Is this the calm before the inevitable storm? To me, the 7175 level is the line in the sand after the recent RTF (Double Top) at 7625, and buyers will need to hold the line if we are to see higher prices. Price has extended into the level so may see a bounce on some bargain hunting in coming sessions although this will largely depend on how the US performs tonight. US bonds are pointing to four rate rises this year which is more than expected and pressuring markets. There are some saying that the US Fed has made a mess of easing and have left it too late to contain inflation so will be chasing with faster tightening. If this is the case, I do not see traders wanting to add risk to portfolios or Funds willing to support price...so now is the time I am happy to be cautious hence the recent short on the ASX200 CFD. Check out our website and follow us on social media.
ASX:XJOShort
by TradeTheStructure
3
BANK NIFTY BUYSIDE 23-09-2021 PriceactnHi I'm Sandeep Deb Price Action Trader. I'm sharing some of my tomorrow setup for a BNF. Tomorrow we can see an aggressive buying above 37120 , aggressive traders can buy above 37050 and safe traders can buy above 37120 with Stop loss @36880 REASON AND SETUP FOR BUYING GIVEN BELOW: 1) In 15min TF we can see down trend and now this trend is going to end or getting weak with confirmation of downtrend rejection, after 5 rejection somewhere there is a high expectation to see for uptrend. 2) 5rejections in downtrend. 3) Cup N Handle pattern. 4) Fib Retracement taking support around 36880.
NSE:BANKNIFTYLong
by sandeepdeb28